826. Decision to Treat Pneumocystis Jirovecii Pneumonia by Combining Molecular Diagnostics and Patient Specific Factors

BACKGROUND: Pneumocystis jirovecii pneumonia (PJP) diagnosis on immunocompromised patients with or without HIV has changed over time. Molecular methods have substituted microscopic methods that can be subjective, labor intensive, and require expertise. Additionally, they can be falsely negative in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Maro, Anna W, Cuellar-Rodriguez, Jennifer, Kline, Ahnika, Das, Sanchita, Hunsberger, Sally
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677914/
http://dx.doi.org/10.1093/ofid/ofad500.871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677914/
http://dx.doi.org/10.1093/ofid/ofad500.871

Ejemplares similares